Search research articles
Contact Us
Filters
Showing results (21-30 of 118) with videos related to
Page
of 12
Sort By:
Arteriosclerosis, Thrombosis, and Vascular Biology
|
September 1, 1995
Fibrinogen and silent atherosclerosis in subjects with cardiovascular risk factors
J Levenson, P Giral, M Razavian, et al.
Alimentary Pharmacology & Therapeutics
|
October 18, 2005
Review article: an unexpected virus-host interaction--the hepatitis C virus-diabetes link
V Ratziu, A Heurtier, L Bonyhay, et al.
Presse Medicale (Paris, France : 1983)
|
May 7, 1988
[High-density cholesterol lipoprotein: metabolism and role in atherosclerosis]
E Bruckert, P Giral, F Dairou, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation
|
August 18, 2011
National differences in screening programmes for cardiovascular risks could obstruct understanding of cardiovascular prevention studies in Europe
S L Thio, Th B Twickler, M J Cramer, et al.
Atherosclerosis
|
September 16, 1999
Cysteine is a cardiovascular risk factor in hyperlipidemic patients
N Jacob, E Bruckert, P Giral, et al.
Journal of Hepatology
|
January 1, 1995
Serum hyaluronan as a marker of liver fibrosis in chronic viral hepatitis C: effect of alpha-interferon therapy
J Guéchot, A Loria, L Serfaty, et al.
Annales Francaises D'Anesthesie Et De Reanimation
|
January 1, 1989
[Lipid parenteral nutrition in resuscitation patients: which emulsion?]
A Soulier, S Cohen, S Froucht, et al.
Journal of Hepatology
|
April 27, 2001
Hepatitis C virus induced hypobetalipoproteinemia: a possible mechanism for steatosis in chronic hepatitis C
L Serfaty, T Andreani, P Giral, et al.
Annales De Medecine Interne
|
June 30, 2001
[New non-lipidic biological markers of atherosclerosis]
J L Beaudeux, N Jacob, P Giral, et al.
Journal of Hepatology
|
July 1, 1994
Factors predictive of the response to interferon in patients with chronic hepatitis C
L Serfaty, P Giral, A Loria, et al.
Page
of 12
Search research articles
Search
Showing results (21-30 of 118) with videos related to
Sort By:
Page
of 12
Arteriosclerosis, Thrombosis, and Vascular Biology
|
September 1, 1995
Fibrinogen and silent atherosclerosis in subjects with cardiovascular risk factors
J Levenson, P Giral, M Razavian, et al.
Alimentary Pharmacology & Therapeutics
|
October 18, 2005
Review article: an unexpected virus-host interaction--the hepatitis C virus-diabetes link
V Ratziu, A Heurtier, L Bonyhay, et al.
Presse Medicale (Paris, France : 1983)
|
May 7, 1988
[High-density cholesterol lipoprotein: metabolism and role in atherosclerosis]
E Bruckert, P Giral, F Dairou, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation
|
August 18, 2011
National differences in screening programmes for cardiovascular risks could obstruct understanding of cardiovascular prevention studies in Europe
S L Thio, Th B Twickler, M J Cramer, et al.
Atherosclerosis
|
September 16, 1999
Cysteine is a cardiovascular risk factor in hyperlipidemic patients
N Jacob, E Bruckert, P Giral, et al.
Journal of Hepatology
|
January 1, 1995
Serum hyaluronan as a marker of liver fibrosis in chronic viral hepatitis C: effect of alpha-interferon therapy
J Guéchot, A Loria, L Serfaty, et al.
Annales Francaises D'Anesthesie Et De Reanimation
|
January 1, 1989
[Lipid parenteral nutrition in resuscitation patients: which emulsion?]
A Soulier, S Cohen, S Froucht, et al.
Journal of Hepatology
|
April 27, 2001
Hepatitis C virus induced hypobetalipoproteinemia: a possible mechanism for steatosis in chronic hepatitis C
L Serfaty, T Andreani, P Giral, et al.
Annales De Medecine Interne
|
June 30, 2001
[New non-lipidic biological markers of atherosclerosis]
J L Beaudeux, N Jacob, P Giral, et al.
Journal of Hepatology
|
July 1, 1994
Factors predictive of the response to interferon in patients with chronic hepatitis C
L Serfaty, P Giral, A Loria, et al.
Page
of 12